[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6584 

# __Virus mutation challenges vaccine development__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Continuous research and development to adapt to virus mutations](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8458.md)

## Name of the risk

Increased difficulty in creating effective vaccines

## People affected by this risk

* [And medical organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3379.md)
* [Vaccine developers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5542.md)

## Stakeholders who can mitigate this risk

* [Research and development teams and medical organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5543.md)

## Technologies linked to the risk

* [Genomic sequencing and antigenic characterization](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_7997.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

